Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
暂无分享,去创建一个
M. Hidalgo | F. Ciardiello | S. Eckhardt | N. Serkova | J. Tentler | T. Pitts | J. Arcaroli | E. Bradshaw-Pierce | M. Morelli | G. Kulikowski | S. Nallapareddy | Amy Brown | A. Tan